Furthermore, Braf oncogenic activation is sufficient to transform Rax+ tanycytes into actively dividing tumor cells that eventually develop into a papillary craniopharyngioma-like tumor. The gene discussed is BRAF; the disease is Papillary Craniopharyngioma.